全文获取类型
收费全文 | 14919篇 |
免费 | 1150篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 220篇 |
儿科学 | 578篇 |
妇产科学 | 363篇 |
基础医学 | 2179篇 |
口腔科学 | 207篇 |
临床医学 | 1588篇 |
内科学 | 2947篇 |
皮肤病学 | 302篇 |
神经病学 | 1433篇 |
特种医学 | 354篇 |
外科学 | 1678篇 |
综合类 | 153篇 |
一般理论 | 12篇 |
预防医学 | 1978篇 |
眼科学 | 210篇 |
药学 | 786篇 |
中国医学 | 4篇 |
肿瘤学 | 1105篇 |
出版年
2023年 | 144篇 |
2022年 | 200篇 |
2021年 | 397篇 |
2020年 | 263篇 |
2019年 | 388篇 |
2018年 | 379篇 |
2017年 | 355篇 |
2016年 | 371篇 |
2015年 | 392篇 |
2014年 | 515篇 |
2013年 | 726篇 |
2012年 | 1078篇 |
2011年 | 1077篇 |
2010年 | 571篇 |
2009年 | 530篇 |
2008年 | 900篇 |
2007年 | 857篇 |
2006年 | 798篇 |
2005年 | 733篇 |
2004年 | 641篇 |
2003年 | 561篇 |
2002年 | 493篇 |
2001年 | 210篇 |
2000年 | 195篇 |
1999年 | 223篇 |
1998年 | 87篇 |
1997年 | 84篇 |
1996年 | 101篇 |
1995年 | 83篇 |
1994年 | 74篇 |
1993年 | 60篇 |
1992年 | 189篇 |
1991年 | 155篇 |
1990年 | 138篇 |
1989年 | 141篇 |
1988年 | 132篇 |
1987年 | 156篇 |
1986年 | 131篇 |
1985年 | 142篇 |
1984年 | 113篇 |
1983年 | 123篇 |
1982年 | 80篇 |
1981年 | 66篇 |
1980年 | 65篇 |
1979年 | 94篇 |
1978年 | 72篇 |
1974年 | 70篇 |
1973年 | 71篇 |
1972年 | 58篇 |
1971年 | 77篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Burkman RT Tang MT Malone KE Marchbanks PA McDonald JA Folger SG Norman SA Strom BL Bernstein L Ursin G Weiss LK Daling JR Simon MS Spirtas R 《Fertility and sterility》2003,79(4):844-851
OBJECTIVE: To determine the association between infertility drug use and invasive breast cancer in a population-based case-control study. DESIGN: Multicenter case-control study. SETTING: Women aged 35 to 64 years in metropolitan Atlanta, Detroit, Los Angeles, Philadelphia, and Seattle. PATIENT(S): The 4,575 case patients had histologically confirmed primary invasive breast cancer. The 4,682 control subjects were women without breast cancer identified in the same geographic locations using randomized-digit dialing. INTERVENTION(S): A standardized questionnaire focusing on reproductive health and family history as well as use of oral contraceptives and other hormones and infertility drugs was administered to all subjects. Data on the type of breast cancer were also obtained. MAIN OUTCOME MEASURE(S): Odds ratios examining the association between use of various infertility drugs and invasive breast cancer. RESULT(S): Overall, a history of infertility drug use was not associated with the risk of developing breast cancer. Compared with women who never used any fertility medication, however, women using human menopausal gonadotropin (hMG) for > or = 6 months or for at least six cycles had a relative risk of breast cancer ranging between 2.7 to 3.8. CONCLUSION(S): Long-term use of certain infertility drugs could adversely affect risk of breast cancer. Additional confirmatory studies are needed. 相似文献
992.
993.
Hormone replacement therapy regimens and breast cancer risk(1) 总被引:3,自引:0,他引:3
Weiss LK Burkman RT Cushing-Haugen KL Voigt LF Simon MS Daling JR Norman SA Bernstein L Ursin G Marchbanks PA Strom BL Berlin JA Weber AL Doody DR Wingo PA McDonald JA Malone KE Folger SG Spirtas R 《Obstetrics and gynecology》2002,100(6):1148-1158
Hormone replacement therapy (HRT) has increased in the United States over the past 2 decades in response to reports of long-term health benefits. A relationship between HRT and breast cancer risk has been observed in a number of epidemiological studies. In 2002, the Women's Health Initiative Randomized Controlled Trial reported an association between continuous combined HRT and breast cancer risk. The objective of this study was to examine the association between breast cancer risk and HRT according to regimen and duration and recency of use.A multicenter, population-based, case-control study was conducted in five United States metropolitan areas from 1994 to 1998. Analyzed were data from 3823 postmenopausal white and black women (1870 cases and 1953 controls) aged 35-64 years. Odds ratios (ORs) were calculated as estimates of breast cancer risk using standard, unconditional, multivariable logistic regression analysis. Potential confounders were included in the final model if they altered ORs by 10% or more. Two-sided P values for trend were computed from the likelihood ratio statistic.Continuous combined HRT was associated with increased breast cancer risk among current users of 5 or more years (1.54; 95% confidence interval 1.10, 2.17). Additionally, a statistically significant trend indicating increasing breast cancer risk with longer duration of continuous combined HRT was observed among current users (P =.01). There were no positive associations between breast cancer risk and other HRT regimens.Our data suggest a positive association between continuous combined HRT and breast cancer risk among current, longer term users. Progestin administered in an uninterrupted regimen may be a contributing factor. Risk dissipates once use is discontinued. 相似文献
994.
995.
Treatment of metastatic osteosarcoma with the somatostatin analog OncoLar: significant reduction of insulin-like growth factor-1 serum levels 总被引:6,自引:0,他引:6
Mansky PJ Liewehr DJ Steinberg SM Chrousos GP Avila NA Long L Bernstein D Mackall CL Hawkins DS Helman LJ 《Journal of pediatric hematology/oncology》2002,24(6):440-446
BACKGROUND: Insulin-like growth factor-1 (IGF-1) has been implicated in the growth and/or metastasis of osteosarcoma (OS) and chondrosarcoma based on in vitro and experimental animal studies. STUDY PURPOSE: To determine the degree of growth hormone (GH), IGF-1 axis blockade, toxicities, and antitumor effect of OncoLar (ONC) (Novartis, East Hanover, NJ, U.S.A.) in OS. DESIGN/METHODS: A phase 1 study with ONC enrolled 21 OS patients (median age 19 y) in four cohorts: ONC 60 mg or 90 mg intramuscularly every 4 weeks with/without tamoxifen (TAM) 20 mg oral daily. RESULTS: There were no dose-limiting toxicities. Nineteen percent of patients had grade III drug-related toxicities including: 62% of patients showed progressive disease after two courses (8 wk). Nineteen percent received four courses. No clinical responses were observed. At weeks two and eight of therapy, IGF-1 serum levels dropped 46% ( < 0.0001, n = 21) and 53% ( = 0.003, n = 10). The difference of the area under the curve (AUC) minus baseline AUC (DeltaAUC) for arginine-stimulated GH serum levels at week two was lower than baseline ( < 0.01). At weeks two and eight, GH peak values were lower than baseline ( < 0.0001 and = 0.002, respectively). CONCLUSIONS: A long-acting somatostatin analog was able to lower IGF-1 levels of OS patients. IGF-BP-3 and GH were only transiently reduced. Although ONC was well tolerated, no sustained clinical responses were observed. The pathophysiology of serum versus tissue concentrations of IGF-1 as well as the interplay of IGFs, IGF-binding proteins, and other growth factors and cytokines in osteosarcoma warrants further investigation. A better understanding of these processes should lead to a more effective exploitation of these pathways for the targeted therapy of OS. 相似文献
996.
997.
Lees CJ Register TC Turner CH Wang T Stancill M Jerome CP 《Menopause (New York, N.Y.)》2002,9(5):320-328
OBJECTIVE: The purpose of this study was to determine the effect of raloxifene on bone density, strength, metabolism, and histomorphometric characteristics in ovariectomized cynomolgus monkeys. DESIGN: A prospective, longitudinal study was designed to examine the effects of conjugated equine estrogens (0.04 mg/kg, CEE) and raloxifene (1 or 5 mg/kg, R1 and R5, respectively) on bone density, biomarkers, histomorphometry, and strength. Control groups included ovariectomized and sham-operated monkeys. Treatment was initiated the day after ovariectomy and continued for 24 months. Bone biomarker data were collected at baseline and every 3 months after surgery. Bone mass was determined at baseline and every 6 months after ovariectomy. Iliac biopsies were collected at baseline and 16 months postovariectomy, and the second lumbar vertebra and left midshaft femur collected at necropsy were examined histomorphometrically. Bone biomechanical properties were determined for the right femur and vertebrae. RESULTS: Compared with the placebo-treated ovariectomized monkeys, the high-dose raloxifene group had lower levels of alkaline phosphatase, tartrate-resistant acid phosphatase, urinary CrossLaps (collagen degradation products), and greater bone mass in the lumbar vertebrae. In the endocortical compartment, the high-dose raloxifene group had significantly lower mineralizing surface, mineral apposition rate, and bone formation rate in the iliac biopsy collected at 16 months and lower bone formation rate in the second lumbar vertebra. Within the midshaft femur, low-dose raloxifene significantly decreased the osteonal and total bone formation rates and also prevented the decrease in Young's modulus induced by ovariectomy in the midshaft femur. CONCLUSIONS: High-dose raloxifene prevented the development of osteopenia in the ovariectomized monkey by reducing bone turnover, albeit to a lesser extent than CEE. Histomorphometric and biomarker data suggest that mechanisms underlying the effect of raloxifene differ somewhat from that of CEE. 相似文献
998.
999.
Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs 总被引:6,自引:0,他引:6
Bourne N Bravo FJ Francotte M Bernstein DI Myers MG Slaoui M Stanberry LR 《The Journal of infectious diseases》2003,187(4):542-549
In two recent clinical trials, a vaccine containing herpes simplex virus (HSV) type 2 glycoprotein D (gD2) and a novel adjuvant AS04 comprising alum (Al) and 3-deactylated monophosphoryl lipid A (3-dMPL) afforded HSV-seronegative women significant protection against HSV-2 genital disease (vaccine efficacy, 73% in study 1 and 74% in study 2) and limited protection against infection (46% in study 1 and 39% in study 2). In the present report, studies in the guinea pig model investigated the protection afforded by gD2/AS04 against HSV-1 and HSV-2 genital herpes and investigated whether immunization could prevent or reduce recurrent disease in guinea pigs that developed mucosal infection. Immunization with gD2/AS04 conveyed nearly complete protection against primary disease with either virus but did not prevent mucosal infection. Guinea pigs immunized with gD2/AS04 were significantly better protected against recurrent disease than were guinea pigs immunized with a gD2/Al vaccine, which suggests that inclusion of 3-dMPL improved protection against latent infection. 相似文献
1000.